Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

CiteULike is a free service for managing and discovering scholarly references - click here to get started.

Sign In to gain access to subscriptions and/or personal tools.
Critical Reviews in Oral Biology & Medicine
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Reibel, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?
14(1):47-62 (2003)     Crit Rev Oral Biol Med
© 2003 International and American Associations for Dental Research

PROGNOSIS OF ORAL PRE-MALIGNANT LESIONS: SIGNIFICANCE OF CLINICAL, HISTOPATHOLOGICAL, AND MOLECULAR BIOLOGICAL CHARACTERISTICS

Jesper Reibel

Department of Oral Pathology & Medicine, School of Dentistry, University of Copenhagen, 20 Nørre Allé, DK-2200 Copenhagen N, Denmark; jesper.reibel{at}odont.ku.dk

The concept of a two-step process of cancer development in the oral mucosa, i.e., the initial presence of a precursor subsequently developing into cancer, is well-established. Oral leukoplakia is the best-known precursor lesion. The evidence that oral leukoplakias are pre-malignant is mainly derived from follow-up studies showing that between < 1 and 18% of oral pre-malignant lesions will develop into oral cancer; it has been shown that certain clinical sub-types of leukoplakia are at a higher risk for malignant transformation than others. The presence of epithelial dysplasia may be even more important in predicting malignant development than the clinical characteristics. Three major problems, however, are attached to the importance of epithelial dysplasia in predicting malignant development: (1) The diagnosis is essentially subjective, (2) it seems that not all lesions exhibiting dysplasia will eventually become malignant and some may even regress, and (3) carcinoma can develop from lesions in which epithelial dysplasia was not diagnosed in previous biopsies. There is, therefore, a substantial need to improve the histologic assessment of epithelial dysplasia or, since epithelial dysplasia does not seem to be invariably associated with or even a necessary prerequisite for malignant development, it may be necessary to develop other methods for predicting the malignant potential of pre-malignant lesions. As a consequence of these problems, numerous attempts have been made to relate biological characteristics to the malignant potential of leukoplakias. Molecular biological markers have been suggested to be of value in the diagnosis and prognostic evaluation of leukoplakias. Markers of epithelial differentiation and, more recently, genomic markers could potentially be good candidates for improving the prognostic evaluation of precursors of oral cancer. As yet, one or a panel of molecular markers has not been determined that allows for a prognostic prediction of oral pre-cancer which is any more reliable than dysplasia recording. However, these new markers could be considered complementary to conventional prognostic evaluation.

Key Words: Leukoplakia • oral pre-cancer • epithelial dysplasia • markers • prognosis

Critical Reviews in Oral Biology & Medicine, Vol. 14, No. 1, 47-62 (2003)
DOI: 10.1177/154411130301400105


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
Clin. Cancer Res.Home page
Y. Li, L.-J. Li, S.-T. Zhang, L.-J. Wang, Z. Zhang, N. Gao, Y.-Y. Zhang, and Q.-M. Chen
In vitro and Clinical Studies of Gene Therapy with Recombinant Human Adenovirus-p53 Injection for Oral Leukoplakia
Clin. Cancer Res., November 1, 2009; 15(21): 6724 - 6731.
[Abstract] [Full Text] [PDF]


Home page
Cancer Prevention ResearchHome page
L. J. Wirth, J. F. Krane, Y. Li, M. Othus, A. E. Moran, D. M. Dorfman, C. M. Norris Jr, L. Goguen, M. R. Posner, R. I. Haddad, et al.
A Pilot Surrogate Endpoint Biomarker Study of Celecoxib in Oral Premalignant Lesions
Cancer Prevention Research, October 1, 2008; 1(5): 339 - 348.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
G. L. Hall, R. J. Shaw, E. A. Field, S. N. Rogers, D. N. Sutton, J. A. Woolgar, D. Lowe, T. Liloglou, J. K. Field, and J. M. Risk
p16 Promoter Methylation Is a Potential Predictor of Malignant Transformation in Oral Epithelial Dysplasia
Cancer Epidemiol. Biomarkers Prev., August 1, 2008; 17(8): 2174 - 2179.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
C. Chen, E. Mendez, J. Houck, W. Fan, P. Lohavanichbutr, D. Doody, B. Yueh, N. D. Futran, M. Upton, D. G. Farwell, et al.
Gene Expression Profiling Identifies Genes Predictive of Oral Squamous Cell Carcinoma
Cancer Epidemiol. Biomarkers Prev., August 1, 2008; 17(8): 2152 - 2162.
[Abstract] [Full Text] [PDF]


Home page
aacredbookHome page
A. B Glick
The High Risk Premalignant Lesion: Experimental Evidence and Clinical Implications
Am. Assoc. Cancer Res. Educ. Book, April 12, 2008; 2008(1): 513 - 516.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
A. J. Yoon, J. Shen, R. M. Santella, D. J. Zegarelli, R. Chen, and I.B. Weinstein
Activated Checkpoint Kinase 2 Expression and Risk for Oral Squamous Cell Carcinoma
Cancer Epidemiol. Biomarkers Prev., December 1, 2007; 16(12): 2768 - 2772.
[Abstract] [Full Text] [PDF]


Home page
Journal of the American Dental AssociationHome page
J. B. Epstein, M. Gorsky, D. Fischer, A. Gupta, M. Epstein, and S. Elad
A Survey of the Current Approaches to Diagnosis and Management of Oral Premalignant Lesions
J Am Dent Assoc, December 1, 2007; 138(12): 1555 - 1562.
[Abstract] [Full Text] [PDF]